We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Eli Lilly Gets Green Light For New Use Of Gemzar

Law360 (July 17, 2006, 12:00 AM EDT) -- The U.S. Food and Drug Administration has given Eli Lilly & Co. the go-ahead to use its drug Gemzar to treat women with recurrent ovarian cancer.

Gemzar, gemcitabine HCl, has received...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.